Surface Plasmon Resonance (SPR) is a powerful, label-free optical technique for measuring biomolecular interactions in real-time. Our SPR platform provides precise kinetic and thermodynamic characterization of protein-protein, protein-small molecule, and protein-nucleic acid interactions.
Technology Principle
SPR detects changes in refractive index near a sensor surface when molecules bind to immobilized ligands. This label-free detection enables real-time monitoring of association and dissociation events with high sensitivity and precision.
Surface Plasmons Electromagnetic waves at metal-dielectric interface
Gold sensor chip surface
Angle-dependent resonance
Refractive index sensitivity
Real-time detection
Binding Detection Mass changes during molecular interactions
Association kinetics (kon)
Dissociation kinetics (koff)
Equilibrium binding (KD)
Thermodynamic parameters
Key Measurements
Kinetic Analysis Affinity Measurements Specificity Studies Real-time binding kinetics with comprehensive rate constant determination
Parameters measured:
Association rate constant (kon): 10³ to 10⁹ M⁻¹s⁻¹
Dissociation rate constant (koff): 10⁻⁶ to 10⁻¹ s⁻¹
Equilibrium dissociation constant (KD = koff/kon)
Residence time (RT = 1/koff)
Applications:
Drug discovery and development
Antibody characterization
Enzyme-substrate interactions
Protein-protein interactions
SPR provides the most comprehensive kinetic characterization available for biomolecular interactions.
Real-time binding kinetics with comprehensive rate constant determination
Parameters measured:
Association rate constant (kon): 10³ to 10⁹ M⁻¹s⁻¹
Dissociation rate constant (koff): 10⁻⁶ to 10⁻¹ s⁻¹
Equilibrium dissociation constant (KD = koff/kon)
Residence time (RT = 1/koff)
Applications:
Drug discovery and development
Antibody characterization
Enzyme-substrate interactions
Protein-protein interactions
SPR provides the most comprehensive kinetic characterization available for biomolecular interactions.
Equilibrium binding analysis for steady-state measurements
Measurement range:
KD values: pM to mM range
Concentration series analysis
Saturation binding curves
Competitive binding assays
Advantages:
Model-independent KD determination
Low sample consumption
Multiple analyte screening
Concentration-response curves
Equilibrium analysis is particularly useful for weak binders or when kinetic analysis is challenging.
Selectivity and cross-reactivity assessment
Applications:
Antibody specificity profiling
Drug selectivity screening
Off-target interaction detection
Biosensor development
Methods:
Multi-cycle kinetics
Single-cycle kinetics
Competition assays
Inhibition studies
Specificity studies are essential for therapeutic development and diagnostic applications.
Experimental Design
Surface Chemistry Selection
Choose appropriate immobilization strategy based on ligand properties and experimental goals.
EDC/NHS chemistry for proteins with accessible primary amines
Advantages:
Stable covalent attachment
High ligand density possible
Well-established protocols
Broad applicability
Considerations:
May affect protein orientation
Multiple attachment points
Requires primary amines
pH sensitivity during coupling
Maleimide or disulfide chemistry for cysteine-containing proteins
Advantages:
Site-specific attachment
Controlled orientation
Mild coupling conditions
Reduced heterogeneity
Applications:
Antibody Fab fragments
Engineered cysteine proteins
Peptide immobilization
Oriented immobilization
His-tag, biotin-streptavidin, or antibody capture
Advantages:
Reversible immobilization
Native protein orientation
Easy regeneration
Minimal protein modification
Applications:
Tagged protein analysis
Protein complex studies
Fragile protein interactions
Screening applications
Ligand Immobilization
Optimize ligand density and activity for reliable kinetic measurements.
Key parameters:
Ligand density: 100-2000 RU (response units)
Activity assessment: analyte binding capacity
Orientation verification: functional binding
Stability testing: long-term performance
High ligand densities can lead to mass transport limitations and artifacts in kinetic analysis.
Analyte Preparation
Prepare analyte samples with appropriate concentration ranges and buffer conditions.
Concentration series:
Typical range: 0.1x to 10x KD
5-8 concentration points
3-fold dilution series
Buffer matching critical
Buffer considerations:
HEPES, PBS, or Tris-based buffers
Physiological salt concentrations
pH 7.0-7.5 (typically)
Additive compatibility assessment
Buffer composition should match immobilization conditions to minimize bulk refractive index changes.
Measurement Protocol
Execute binding experiments with appropriate controls and reference subtraction.
Typical protocol:
Baseline stabilization (2-5 minutes)
Analyte injection (association phase)
Buffer injection (dissociation phase)
Regeneration (if applicable)
Reference subtraction
Include reference flow cells and negative controls to ensure data quality and specificity.
Data Analysis and Modeling
Kinetic Modeling
Simple bimolecular interaction (A + B ⇌ AB)
Assumptions:
Single binding site
Homogeneous analyte
No mass transport limitation
Reversible binding
Applications:
Simple protein-protein interactions
Small molecule binding
Antibody-antigen interactions
Initial screening studies
Equation: dR/dt = kon × Ca × (Rmax - R) - koff × R
Conformational change upon binding (A + B ⇌ AB ⇌ AB*)
Features:
Initial binding step
Conformational rearrangement
Improved fit quality
Biological relevance
Applications:
Enzyme-substrate interactions
Allosteric binding
Conformational changes
Complex binding mechanisms
Heterogeneous Ligand Model
Multiple binding sites or populations
Features:
Multiple KD values
Different binding capacities
Population analysis
Improved data fitting
Applications:
Heterogeneous ligand preparations
Multiple binding sites
Avidity effects
Complex interactions
Quality Control Metrics
Kinetic Quality Kinetic parameter reliability
Chi-squared (χ²) values <10
Residuals analysis
Parameter standard errors
Model comparison statistics
Experimental Quality Data collection quality
Signal-to-noise ratio >20
Baseline stability (±2 RU)
Injection reproducibility
Reference subtraction quality
Binding Quality Interaction specificity
Specific vs. non-specific binding
Dose-response relationships
Saturation behavior
Competition studies
Surface Quality Sensor surface performance
Ligand activity maintenance
Regeneration efficiency
Surface stability
Drift assessment
Advanced SPR Techniques
Multi-Cycle vs. Single-Cycle Kinetics
Multi-Cycle Kinetics Single-Cycle Kinetics Individual injections for each analyte concentration
Advantages:
Complete dissociation between cycles
Full kinetic information per concentration
Better curve fitting
Traditional approach
Applications:
High-quality kinetic analysis
Method development
Detailed characterization
Publication-quality data
Considerations:
Longer analysis time
More sample consumption
Surface regeneration required
Potential surface degradation
Individual injections for each analyte concentration
Advantages:
Complete dissociation between cycles
Full kinetic information per concentration
Better curve fitting
Traditional approach
Applications:
High-quality kinetic analysis
Method development
Detailed characterization
Publication-quality data
Considerations:
Longer analysis time
More sample consumption
Surface regeneration required
Potential surface degradation
Sequential injections without regeneration
Advantages:
Faster analysis
Reduced sample consumption
No regeneration artifacts
Better for fragile surfaces
Applications:
High-throughput screening
Fragile interaction analysis
Limited sample availability
Routine analysis
Limitations:
Less kinetic information
Requires stable surfaces
Model-dependent analysis
Limited concentration range
Specialized Applications
Low molecular weight compound screening for drug discovery:
Challenges:
Low molecular weight signals
Weak binding affinities
High compound concentrations
Solubility limitations
Solutions:
High ligand density surfaces
Optimized buffer systems
Statistical analysis methods
Hit validation protocols
Throughput: 100-1000 compounds per day
Antibody Characterization
Comprehensive antibody analysis including epitope binning:
Measurements:
Binding kinetics and affinity
Epitope mapping studies
Species cross-reactivity
Isotype comparisons
Applications:
Therapeutic antibody development
Diagnostic antibody selection
Biosimilar characterization
Quality control testing
Protein-Protein Interactions
Complex formation and interaction network analysis:
Capabilities:
Binary interaction analysis
Competitive binding studies
Ternary complex formation
Allosteric effect detection
Applications:
Signaling pathway studies
Drug mechanism of action
Protein function analysis
Interaction validation
Integration with Other Technologies
SPR measurements complement other biophysical techniques:
Structural Studies Validate binding sites identified by crystallography or NMR
Confirm solution-phase binding
Quantify binding strength
Assess binding kinetics
Structure-activity relationships
Cell-Based Assays Correlate molecular binding with cellular activity
Binding vs. functional potency
Selectivity confirmation
Mechanism validation
Dose-response relationships
Computational Modeling Validate predictions from molecular modeling
Docking score correlation
Binding mode validation
Affinity predictions
Drug design optimization
Other Biophysics Orthogonal binding measurements
ITC thermodynamics
BLI kinetics comparison
MST binding confirmation
NMR interaction mapping
Quality Assurance and Compliance
Method Validation
Precision and Accuracy
Assess method repeatability and reproducibility across operators and instruments.
Acceptance criteria:
Kinetic rate constants: CV <20%
Equilibrium KD values: CV <30%
Inter-analyst precision: CV <25%
Long-term reproducibility: CV <35%
Range and Linearity
Establish working ranges for kinetic and equilibrium measurements.
Kinetic range:
kon: 10³ to 10⁸ M⁻¹s⁻¹
koff: 10⁻⁵ to 10⁻¹ s⁻¹
KD: pM to μM range
Linearity assessment:
Concentration vs. response
Rate vs. concentration plots
Binding capacity analysis
Robustness Testing
Evaluate method performance under varied conditions.
Test parameters:
Buffer composition variations
Temperature fluctuations (±2°C)
Flow rate changes (±10%)
Injection volume variations (±5%)
Regulatory Compliance
ICH guidelines for bioanalytical method validation:
Accuracy and precision requirements
Selectivity and specificity
Stability and robustness
Quality control procedures
Data integrity requirements:
21 CFR Part 11 compliance
Audit trail maintenance
Electronic signature controls
Data backup and archival
SPR measurements require careful attention to mass transport effects, which can lead to apparent kinetic artifacts if not properly controlled.
Troubleshooting Common Issues
Mass Transport Limitations
Symptoms: Concentration-dependent kinetics, curved Scatchard plots, reduced apparent kon
Solutions:
Reduce ligand density (target 100-500 RU)
Increase flow rate (≥30 μL/min)
Use shorter contact time
Consider single-cycle kinetics
Prevention:
Optimize ligand immobilization levels
Use appropriate flow rates from the start
Monitor for concentration-dependent artifacts
Bulk Refractive Index Effects
Symptoms: Large baseline shifts, poor reference subtraction, drift
Solutions:
Match analyte and running buffer exactly
Include buffer blanks in sequence
Use appropriate reference flow cells
Filter all solutions (0.22 μm)
Prevention:
Careful buffer preparation and matching
Consistent sample preparation procedures
Regular instrument maintenance
Symptoms: High responses to negative controls, poor specificity
Solutions:
Optimize surface chemistry and blocking
Include appropriate negative controls
Use competitor molecules
Increase salt concentration moderately
Prevention:
Proper surface preparation and blocking
Include specificity controls in all experiments
Use well-characterized negative control proteins
Symptoms: Decreased binding capacity over cycles, baseline drift
Solutions:
Optimize regeneration conditions
Use milder regeneration (shorter time, lower concentration)
Consider alternative regeneration agents
Replace sensor chip if necessary
Prevention:
Test regeneration conditions during method development
Monitor binding capacity over time
Use appropriate regeneration protocols
Best Practices and Recommendations
Experimental Design
Control experiments : Always include negative controls and reference surfaces
Concentration series : Use appropriate concentration ranges (0.1x to 10x KD)
Buffer optimization : Match all buffer conditions between ligand and analyte
Surface validation : Confirm ligand activity and orientation
Data Quality
Baseline stability : Ensure stable baselines before and after injections
Reference subtraction : Use appropriate reference flow cells
Reproducibility : Include replicate measurements for key interactions
Model validation : Compare different kinetic models and assess fit quality
Method Development
Ligand optimization : Test different immobilization strategies and densities
Kinetic validation : Confirm mass transport-free conditions
Specificity testing : Include comprehensive specificity panels
Robustness assessment : Test method performance under varied conditions
Regular instrument maintenance and calibration are essential for consistent, high-quality SPR results. Our team provides comprehensive training and support for SPR method development and validation.
Responses are generated using AI and may contain mistakes.